The Birth of the American Society of Gene Therapy

Abstract

In the spring of 1996, the field of human gene therapy was flying high. Many pioneering developments were receiving high exposure in the lay press. Several gene therapy biotechnology companies were operating, and new ones were being formed. Major pharmaceutical companies had established gene therapy initiatives. Medical schools were rushing to establish gene therapy programs. Conferences on human gene therapy were being organized, and well-established gene therapy investigators were filling the programs.